Poor Takeda. They have denied they failed to declare 122.3 billion yen (US$1.05 billion; euro0.84 billion) in taxable income over six years to March 2005, rebuffing claims by tax authorities and saying it will fight an order to pay back taxes.
The Osaka Regional Tax bureau on Wednesday said it would impose back taxes worth 57 billion yen (US$491 million; euro390.61 million) because Takeda's stated profits did not accurately reflect revenue from transactions between Takeda and TAP Pharmaceutical Products Inc., which Takeda operates jointly with the U.S. company Abbott Laboratories.
TAP have had a few mentions on PharmaGossip (here, and here, for example)!
Who to believe............ that's the question!
More here.
No comments:
Post a Comment